Investor directoryYsios Capital
Ysios Capital specializes in financing highly innovative biotech ventures with a focus on transformative therapeutics.
What they invest in
Sectors
Geographies
EuropeWorldwide
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- San Sebastián, Spain
- Founded
- 2007
More portfolio companies
Damora Therapeutics (Biotechnology) (NAS: DMRA)AM-PharmaLava TherapeuticsSanifitTagworksKynexisVivet TherapeuticsVarmXAura Biosciences (NAS: AURA)Mineralys (NAS: MLYS)Prexton TherapeuticsNorthSea TherapeuticsCVRx (NAS: CVRX)MinoryxCorWaveRainier TherapeuticsBabyscriptsMedLumicsSparingVisionSynendos TherapeuticsCytokiInbiomotionReproNovoMemo Therapeutics
and 3 more
Questions founders ask
- How much does Ysios Capital typically invest?
- Ysios Capital states a typical cheque of €1M – €30M.
- Which stages does Ysios Capital invest in?
- Ysios Capital invests at Seed, Series A and Series B.
- Where is Ysios Capital based?
- Ysios Capital is headquartered in San Sebastián, Spain.
Does Ysios Capital fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Ysios Capital? Tell us what to correct and we will update it — or ask us to remove the entry.